Optimizing Clinical Trial Design & Outcomes for Inflammasome-Targeted Therapies

Time: 9:00 am
day: Day 2


  • Investigate innovative methodologies for enhancing trial efficiency without sacrificing data quality
  • Delve into the utilization of biomarkers and surrogate endpoints to enable faster assessments of therapeutic efficacy and safety, facilitating expedited decision-making in clinical trials
  • Examine strategies for enhancing patient recruitment and retention, addressing common challenges to ensure timely completion of trials and robust data interpretation